BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31213801)

  • 1. Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection.
    Marazioti A; Papadia K; Giannou A; Stathopoulos GT; Antimisiaris SG
    Int J Nanomedicine; 2019; 14():3773-3784. PubMed ID: 31213801
    [No Abstract]   [Full Text] [Related]  

  • 2. Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed.
    Ando H; Kobayashi S; Abu Lila AS; Eldin NE; Kato C; Shimizu T; Ukawa M; Kawazoe K; Ishida T
    J Control Release; 2015 Dec; 220(Pt A):29-36. PubMed ID: 26476173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion.
    Li X; Wu G; Chen C; Zhao Y; Zhu S; Song X; Yin J; Lv T; Song Y
    Front Immunol; 2021; 12():760683. PubMed ID: 34966384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutical effects of pleural injecting recombinant human endostain to 
malignant pleural effusion nude mice model].
    Zhou M; Li M; Yang H; Hu C
    Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):266-71. PubMed ID: 25975296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Safety and Exploration of the Pharmacokinetics of Intrapleural Liposomal Curcumin.
    Hocking A; Tommasi S; Sordillo P; Klebe S
    Int J Nanomedicine; 2020; 15():943-952. PubMed ID: 32103948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion.
    Psallidas I; Stathopoulos GT; Maniatis NA; Magkouta S; Moschos C; Karabela SP; Kollintza A; Simoes DC; Kardara M; Vassiliou S; Papiris SA; Roussos C; Kalomenidis I
    Oncogene; 2013 Jan; 32(4):528-35. PubMed ID: 22370646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion.
    Liu Y; Wang L; Song Q; Ali M; Crowe WN; Kucera GL; Hawkins GA; Soker S; Thomas KW; Miller LD; Lu Y; Bellinger CR; Zhang W; Habib AA; Petty WJ; Zhao D
    Nat Nanotechnol; 2022 Feb; 17(2):206-216. PubMed ID: 34916656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.
    Lombardi G; Nicoletto MO; Gusella M; Fiduccia P; Dalla Palma M; Zuin A; Fiore D; Donach M; Zagonel V
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):781-7. PubMed ID: 22037881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.
    Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM
    J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring with a non-invasive bioluminescent in vivo imaging system of pleural metastasis of lung carcinoma.
    Matsumoto S; Tanaka F; Sato K; Kimura S; Maekawa T; Hasegawa S; Wada H
    Lung Cancer; 2009 Oct; 66(1):75-9. PubMed ID: 19178977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
    Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I
    J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of intrapleural pingyangmycin administration on activity of fibrinolytic system and transforming growth factor-beta1 in malignant pleural effusion].
    Zhu QQ; Sun GY
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):674-8. PubMed ID: 20079281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cells mediate malignant pleural effusion formation.
    Giannou AD; Marazioti A; Spella M; Kanellakis NI; Apostolopoulou H; Psallidas I; Prijovich ZM; Vreka M; Zazara DE; Lilis I; Papaleonidopoulos V; Kairi CA; Patmanidi AL; Giopanou I; Spiropoulou N; Harokopos V; Aidinis V; Spyratos D; Teliousi S; Papadaki H; Taraviras S; Snyder LA; Eickelberg O; Kardamakis D; Iwakura Y; Feyerabend TB; Rodewald HR; Kalomenidis I; Blackwell TS; Agalioti T; Stathopoulos GT
    J Clin Invest; 2015 Jun; 125(6):2317-34. PubMed ID: 25915587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha promotes malignant pleural effusion.
    Stathopoulos GT; Kollintza A; Moschos C; Psallidas I; Sherrill TP; Pitsinos EN; Vassiliou S; Karatza M; Papiris SA; Graf D; Orphanidou D; Light RW; Roussos C; Blackwell TS; Kalomenidis I
    Cancer Res; 2007 Oct; 67(20):9825-34. PubMed ID: 17942913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered lactococcus lactis intrapleural therapy promotes regression of malignant pleural effusion by enhancing antitumor immunity.
    Fan Y; Chen A; Zhu J; Liu R; Mei Y; Li L; Sha X; Wang X; Ren W; Wang L; Liu B
    Cancer Lett; 2024 Apr; 588():216777. PubMed ID: 38432582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
    Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
    Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapleural Trastuzumab Therapy for Malignant Pleural Effusion from HER2 Overexpression in Metastatic Gastric Cancer.
    Orlandi E; Mordenti P; Zangrandi A; Cavanna L
    Chemotherapy; 2014; 60(5-6):321-4. PubMed ID: 26279275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients.
    Shimizu T; Takahashi N; Terakado M; Akusawa H; Tsujino I; Horie T
    Intern Med; 2006; 45(11):715-20. PubMed ID: 16819251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of malignant pleural effusion.
    Stathopoulos GT; Kalomenidis I
    Curr Opin Pulm Med; 2009 Jul; 15(4):343-52. PubMed ID: 19387350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.